Cargando…

Urinary Plasmin(ogen): New Predictor of Hypertension?

Detalles Bibliográficos
Autor principal:	Kohan, Donald E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224785/ https://www.ncbi.nlm.nih.gov/pubmed/30450446 http://dx.doi.org/10.1016/j.ekir.2018.07.012

Ejemplares similares

Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension
por: Ray, Evan C., et al.
Publicado: (2018)

Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice
por: Guo, Yongzhi, et al.
Publicado: (2011)

Expression and ultrastructural localization of plasmin(ogen) in the terminally differentiated layers of normal human epidermis
por: Voegeli, R., et al.
Publicado: (2019)

Bacillus anthracis Interacts with Plasmin(ogen) to Evade C3b-Dependent Innate Immunity
por: Chung, Myung-Chul, et al.
Publicado: (2011)

The Complement Binding and Inhibitory Protein CbiA of Borrelia miyamotoi Degrades Extracellular Matrix Components by Interacting with Plasmin(ogen)
por: Nguyen, Ngoc T. T., et al.
Publicado: (2018)

Plasmin as a complement C5 convertase
por: Leung, Lawrence L., et al.
Publicado: (2016)

ANGPTL4/8 promotes plasmin-mediated cleavage of LPL inhibitors
por: Kersten, Sander
Publicado: (2023)

Plasmin and Articular Cartilage
por: Chrisman, O. Donald, et al.
Publicado: (1962)

Integrative Cancer Genomics (IntOGen) in Biomart
por: Perez-Llamas, Christian, et al.
Publicado: (2011)

Fibrin(ogen) mediates acute inflammatory responses to biomaterials
Publicado: (1993)

Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
por: Wen, Tingting, et al.
Publicado: (2023)

Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis
por: Miyazaki, Kanji, et al.
Publicado: (2018)

STUDIES OF THE PLASMIN SYSTEM : III. PHYSICAL PROPERTIES OF THE TWO PLASMIN INHIBITORS IN PLASMA
por: Norman, Philip S., et al.
Publicado: (1958)

Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study
Publicado: (2012)

IntOGen-mutations identifies cancer drivers across tumor types
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study
por: Panoutsopoulou, K, et al.
Publicado: (2010)

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin
Publicado: (1977)

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013)

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019)

Physical Activity, Weight Loss, and Weight Maintenance in the DiOGenes Multicenter Trial
por: van Baak, Marleen A., et al.
Publicado: (2021)

A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats
por: Iwata, Yasunobu, et al.
Publicado: (2023)

THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Pillemer, Louis, et al.
Publicado: (1953)

Does plasmin have anticoagulant activity?
por: Hoover-Plow, Jane
Publicado: (2010)

Assessing Plasmin Generation in Health and Disease
por: Miszta, Adam, et al.
Publicado: (2021)

Plasmin, Immunity, and Surgical Site Infection
por: Hastings, Stuart, et al.
Publicado: (2021)

Genetic Polymorphisms in the Hypothalamic Pathway in Relation to Subsequent Weight Change – The DiOGenes Study
por: Du, Huaidong, et al.
Publicado: (2011)

In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai
por: Bae, Seong Kyeong, et al.
Publicado: (2017)

Fibrin(ogen) Is Constitutively Expressed by Differentiated Intestinal Epithelial Cells and Mediates Wound Healing
por: Seltana, Amira, et al.
Publicado: (2022)

Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition
por: Fox, Tilly, et al.
Publicado: (2023)

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients
por: Fawzy, Rasha, et al.
Publicado: (2022)

Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme
por: Deryugina, Elena I., et al.
Publicado: (2012)

Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein
por: Ishiguro, Kazuya, et al.
Publicado: (2017)

The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6
por: Cole, Heather A., et al.
Publicado: (2021)

Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species
por: Petraglia, Tania, et al.
Publicado: (2022)

INCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN
por: Ratnoff, Oscar D.
Publicado: (1965)

Cannot write session to /tmp/vufind_sessions/sess_4for0grenckeu9mg65s0uqgbdd